There was no substantial change in cathepsin B expression following treatment with exogenous HRG (Figure 6E), but there was a significant increase in extracellular cathepsin B activity in all three breast cancer cell lines (Figure 6F). This evidence concerns the gene CTSB and breast carcinoma.